![]() Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology. | ||
Founding Date | Founding Date 1995 | Founding Date 2017 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more | Locations Cambridge, US HQ |
Employees | Employees 20216% increase | Employees 60 |
Valuation ($) | Valuation ($) 737.4 m | Valuation ($) 68.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $49.8m (FY, 2025) | Revenue (est.) $3.1m (FY, 2023) |
Net income | Net income ($50.3m) (FY, 2025) | Net income ($97.4m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 244.7m | Total funding raised $ 211m |
Omega Therapeutics is an epigenomic medicine company.
View company